QSI
Quantum-Si incorporated1.2200
-0.0100-0.81%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
262.90MP/E (TTM)
-Basic EPS (TTM)
-0.67Dividend Yield
0%Recent Filings
8-K
10-Q
8-K
8-K
Quantum-Si settles lease dispute
Quantum-Si Incorporated settled a lawsuit with landlord Winchester Office LLC over a disputed lease for its New Haven, CT premises, terminating the agreement early on September 23, 2025, originally set to run until 2032. The company will pay a net $10.2 million termination fee, including forfeiture of its $573,214 security deposit and credit for September's $272,618 rent. This frees Quantum-Si from future rent obligations while resolving all claims. Litigation costs stay with each party.
8-K
Quantum-Si updates proteomics roadmap
Quantum-Si Incorporated updated its corporate presentation on August 8, 2025, highlighting a $75B+ proteomics market opportunity and its Platinum Pro instrument driving 33% year-over-year user base growth in early 2025. The company outlined a robust innovation roadmap, including the V4 Sequencing Kit in Q3 2025 and Proteus platform launch in second-half 2026, to scale throughput and enable de novo sequencing. Adjusted operating expenses are guided at $98M or less for 2025, extending cash runway into Q2 2028. Yet risks from product development timelines loom large.
BRKR
Bruker Corporation
44.96-0.71
DGX
Quest Diagnostics Incorporated
178.66-5.45
LAB
Standard BioTools Inc.
1.49-0.02
NOVT
Novanta Inc.
121.36+1.95
PACB
Pacific Biosciences of Californ
2.02-0.10
QDEL
QuidelOrtho Corporation
28.88-0.18
QGEN
Qiagen N.V.
45.01-0.43
QTIH
QT Imaging Holdings, Inc.
6.10-0.02
QTRX
Quanterix Corporation
7.36-0.05
QTZM
Quantumzyme Corp.
3.18+0.02